Diffuse dermal angiomatosis with clinical features simulating calciphylaxis in the setting of end-stage renal disease

[1]  M. Rosenblum,et al.  Warfarin-Associated Nonuremic Calciphylaxis , 2017, JAMA dermatology.

[2]  M. Kamdar,et al.  Calciphylaxis: risk factors, diagnosis, and treatment. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  V. Vachiramon,et al.  Diffuse Dermal Angiomatosis: A Clue to the Diagnosis of Atherosclerotic Vascular Disease , 2015, Case Reports in Dermatology.

[4]  Katherine T. Steele,et al.  Diffuse dermal angiomatosis associated with calciphylaxis in a patient with end‐stage renal disease , 2013, Journal of cutaneous pathology.

[5]  J. Guitart,et al.  Diffuse Dermal Angiomatosis Associated With Calciphylaxis , 2009, The American Journal of dermatopathology.

[6]  M. Pittelkow,et al.  Calciphylaxis: natural history, risk factor analysis, and outcome. , 2007, Journal of the American Academy of Dermatology.

[7]  A. Boyd,et al.  Diffuse dermal angiomatosis , 2006, Journal of cutaneous pathology.

[8]  A. Rebora,et al.  Cutaneous reactive angiomatoses: patterns and classification of reactive vascular proliferation. , 2003, Journal of the American Academy of Dermatology.

[9]  A. Fine,et al.  Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy. , 2002, Kidney international.

[10]  L. Requena,et al.  Intravascular and diffuse dermal reactive angioendotheliomatosis secondary to iatrogenic arteriovenous fistulas , 1999, Journal of cutaneous pathology.